Pharvaris N.V. (PHVS) Insider Trading
Over the last 3 months, PHVS insiders made 0 open-market buys and 30 sales, a net sale of -$6.6M (SEC Form 4). Over the last 6 months, 82 institutions increased and 51 reduced their position (13F).
Insider Activity
Sentiment
0/100
Buys (3m)
0
Sells (3m)
30
Net (3m)
-$6.6M
Insider trades by month Buys Sells
Apr
May
Context3-month price +12.5%Institutions accumulating (13F)
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| May 26, 2026 | Nijdam Annaofficer: Principal Accounting Officer | Option | 5,501 | $20.00 |
| May 26, 2026 | Nijdam Annaofficer: Principal Accounting Officer | Sell | 1,829 | $30.60 |
| May 26, 2026 | Nijdam Annaofficer: Principal Accounting Officer | Option | 1,829 | $20.00 |
| May 26, 2026 | Monges Vivianedirector | Sell | 9,667 | $30.29 |
| May 26, 2026 | Nassif David W.officer: CFO / CLO | Sell | 10,000 | $30.31 |
| May 26, 2026 | Nijdam Annaofficer: Principal Accounting Officer | Sell | 5,501 | $30.74 |
| May 22, 2026 | Bjork Elisabethdirector | Sell | 10,000 | $29.32 |
| May 22, 2026 | Bjork Elisabethdirector | Option | 10,000 | $8.05 |
| May 20, 2026 | Modig Berndtdirector, officer: Chief Executive Officer | Sell | 2,292 | $29.22 |
| May 19, 2026 | Glassman Robertdirector | Sell | 4,667 | $29.82 |
| May 19, 2026 | Glassman Robertdirector | Sell | 5,333 | $29.83 |
| May 19, 2026 | Glassman Robertdirector | Option | 5,333 | $22.31 |
| May 19, 2026 | Souverijns Wimofficer: Chief Commercial Officer | Sell | 10,000 | $29.92 |
| May 19, 2026 | Abele Stefan Andreasofficer: Chief Technical Ops Officer | Sell | 8,748 | $29.82 |
| May 13, 2026 | Lu Pengofficer: Chief Medical Officer | Tax | 117 | $29.95 |
| May 13, 2026 | Lu Pengofficer: Chief Medical Officer | Tax | 109 | $30.09 |
| May 5, 2026 | Lu Pengofficer: Chief Medical Officer | Option | 14,023 | $2.59 |
| May 5, 2026 | Lu Pengofficer: Chief Medical Officer | Option | 14,166 | $2.59 |
| May 5, 2026 | Lu Pengofficer: Chief Medical Officer | Sell | 143 | $31.00 |
| May 5, 2026 | Lu Pengofficer: Chief Medical Officer | Option | 143 | $2.59 |
| May 5, 2026 | Lu Pengofficer: Chief Medical Officer | Sell | 14,023 | $30.16 |
| May 1, 2026 | Lesage Anneofficer: Chief Early Development | Sell | 19,200 | $30.26 |
| May 1, 2026 | Schikan Johannes Gerardus Christiaan Petrusdirector | Sell | 3,830 | $30.07 |
| May 1, 2026 | Schikan Johannes Gerardus Christiaan Petrusdirector | Sell | 28,400 | $30.30 |
| May 1, 2026 | Schikan Johannes Gerardus Christiaan Petrusdirector | Sell | 670 | $31.03 |
| May 1, 2026 | Lesage Anneofficer: Chief Early Development | Option | 3,700 | $2.59 |
| May 1, 2026 | Lesage Anneofficer: Chief Early Development | Sell | 3,700 | $30.08 |
| May 1, 2026 | Lesage Anneofficer: Chief Early Development | Sell | 18,000 | $30.26 |
| May 1, 2026 | Lesage Anneofficer: Chief Early Development | Option | 18,000 | $8.05 |
| May 1, 2026 | Lu Pengofficer: Chief Medical Officer | Option | 3,733 | $2.59 |
Source: PHVS SEC Form 4 filings, latest May 26, 2026. For informational purposes only — not investment advice.
Institutional activity (13F)
How institutions changed their PHVS positions over the last 6 months (SEC Form 13F).
Increased
82
New positions
38
Reduced
51
Sold out
11
Largest moves
| Institution | Action | Shares | Filed |
|---|---|---|---|
| GENERAL ATLANTIC, L.P. | Unchanged | 8.0M | May 15, 2026 |
| GENERAL ATLANTIC, L.P. | Unchanged | 8.0M | Feb 17, 2026 |
| FMR LLC | Unchanged | 6.4M | Feb 17, 2026 |
| FMR LLC | Reduced | 6.3M | May 15, 2026 |
| FORESITE CAPITAL MANAGEMENT IV, LLC | Unchanged | 4.8M | Feb 17, 2026 |
| FORESITE CAPITAL MANAGEMENT IV, LLC | Unchanged | 4.8M | May 15, 2026 |
| VENBIO PARTNERS LLC | Unchanged | 4.6M | May 15, 2026 |
| VENBIO PARTNERS LLC | Unchanged | 4.6M | Feb 17, 2026 |
| VIKING GLOBAL INVESTORS LP | Unchanged | 3.7M | May 15, 2026 |
| VIKING GLOBAL INVESTORS LP | Unchanged | 3.7M | Feb 17, 2026 |
| EQT FUND MANAGEMENT S.A R.L. | Unchanged | 3.4M | Feb 11, 2026 |
| EQT FUND MANAGEMENT S.A R.L. | Unchanged | 3.4M | May 14, 2026 |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | Unchanged | 3.1M | May 15, 2026 |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | Increased | 3.1M | Feb 17, 2026 |
| BAIN CAPITAL LIFE SCIENCES INVESTORS, LLC | Reduced | 2.8M | Feb 17, 2026 |
Source: SEC Form 13F filings. For informational purposes only — not investment advice.